NasdaqGM - Nasdaq Real Time Price USD

Eton Pharmaceuticals, Inc. (ETON)

17.35
+0.56
+(3.34%)
At close: May 12 at 4:00:01 PM EDT
17.68
+0.33
+(1.90%)
Pre-Market: 8:39:44 AM EDT

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
BAUM MARK L Director Purchase Nov 15, 2018 --
BRYNJELSEN SEAN E Chief Executive Officer Purchase Sep 22, 2022 1,064,940
CASAMENTO CHARLES J Director Stock Gift Mar 19, 2020 68,420
IMPRIMIS PHARMACEUTICALS INC Beneficial Owner of more than 10% of a Class of Security Sale Apr 12, 2021 1,982,000
MAIER PAUL V Director Purchase Nov 15, 2018 59,745
OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security Purchase Oct 23, 2024 --
RIEDEL NORBERT G Director Conversion of Exercise of derivative security Jan 3, 2025 162,145
TROUTMAN WILLIAM WILSON Chief Financial Officer Purchase Aug 20, 2021 23,027

Related Tickers